Despite advances in the treatment of myocardial infarction (MI), the incidence of cardiogenic shock has remained at 7% to 10% during the last 25 years. Hospital mortality was about 90% in the ...

shock from other causes (e.g., sepsis, hypovolemia), prior severe systemic illness, refusal by the patient's physician, and failure to provide informed consent. All participating sites had ...

Adrenomed AG is translating the concept of precision medicine to acute care with a biomarker-guided antibody therapy for sepsis and septic shock. With a mortality rate of 20–30% in developed ...

Dr. Alexandre Mebazaa is Professor of Medicine at Université Paris Cité (France), Chair of Department of Anesthesia & Critical Care and an expert in heart failure and cardiogenic shock.

determined that the girl was suffering from refractory septic shock that had led to cardiac and cardiogenic shock, resistant to all conventional treatments. Advanced measures were initiated, including ...

Cardiogenic shock occurs when the heart is not able to pump enough blood to generate adequate cardiac output to maintain normal blood pressure. This frequently occurs in the setting of a large ...